COVID-19 and Alzheimer’s disease in the ADNI cohort

INTRODUCTION: There is growing evidence that COVID-19 infection in older adults increases the risk of diagnosis of Alzheimer’s disease and accelerates cognitive decline. We hypothesized that participants reporting COVID-19 infection would have greater cognitive and functional decline and greater occurrence of neuropsychiatric symptoms after COVID-19 infection in comparison to uninfected matched controls. METHODS This secondary data analysis from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort examined participants with and without self-reported history of COVID-19 infection comparing visits before and after infection. RESULTS The 16 participants included in the COVID-19 cohort and the 32 controls, had similar changes in cognitive, functionality and behavioral measures between study visits. CONCLUSIONS While there is evidence that COVID-19 infection increases the risk for depression, cognitive changes and conversion to dementia, this examination of a well characterized cohort of at risk and cognitive impaired individuals did not find evidence for the impact of COVID-19 after infection.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-20
DOI
https://doi.org/10.21203/rs.3.rs-11089141/v1
Primary Topic
Long-Term Effects of COVID-19
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

COVID-19 and Alzheimer’s disease in the ADNI cohort

Warren D. Taylor, Patricia Andrews, Ke Xu, Paul Newhouse et al.
5 links
Research Square
Long-Term Effects of COVID-19
preprint

COVID-19 and Alzheimer’s disease in the ADNI cohort

Warren D. Taylor, Patricia Andrews, Ke Xu, Paul Newhouse, Brian Boyd, Kathleen Mather, Hakmook Kang, Kiara Baker
preprint en

Abstract

INTRODUCTION: There is growing evidence that COVID-19 infection in older adults increases the risk of diagnosis of Alzheimer’s disease and accelerates cognitive decline. We hypothesized that participants reporting COVID-19 infection would have greater cognitive and functional decline and greater occurrence of neuropsychiatric symptoms after COVID-19 infection in comparison to uninfected matched controls. METHODS This secondary data analysis from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort examined participants with and without self-reported history of COVID-19 infection comparing visits before and after infection. RESULTS The 16 participants included in the COVID-19 cohort and the 32 controls, had similar changes in cognitive, functionality and behavioral measures between study visits. CONCLUSIONS While there is evidence that COVID-19 infection increases the risk for depression, cognitive changes and conversion to dementia, this examination of a well characterized cohort of at risk and cognitive impaired individuals did not find evidence for the impact of COVID-19 after infection.

Research Square
University of North Carolina at Chapel Hill (US), Yale University (US), Vanderbilt University Medical Center (US)
Good health and well-being
Long-Term Effects of COVID-19
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon